Atherogenic lipoproteins as treatment targets

被引：4

作者：

Catapano, Alberico L. ^{[1
,2
]}

机构：

[1] Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, I-20133 Milan, Italy

[2] IRCCS MultiMed, Via Milanese 100, I-20099 Milan, Italy

来源：

NATURE REVIEWS CARDIOLOGY | 2018年 / 15卷 / 02期

关键词：

CHOLESTEROL; RISK;

D O I：

10.1038/nrcardio.2017.221

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Research on dyslipidaemias in 2017 reaffirmed the central role of reducing the levels of atherogenic apolipoprotein B-containing lipoproteins, predominantly LDL, in preventing ischaemic cardiovascular events. However, whether increasing HDL-cholesterol levels in isolation can reduce cardiovascular risk remains to be determined.

引用

页码：221 / +

页数：2

共 10 条

[1]

[Anonymous], 2017, CELL METAB, DOI [DOI 10.1016/j.cmet.2017.07.012, DOI 10.1136/BMJ.J1648]

[2] Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management [J].

Galabova, Gergana ;

Brunner, Sylvia ;

Winsauer, Gabriele ;

Juno, Claudia ;

Wanko, Bettina ;

Mairhofer, Andreas ;

Luehrs, Petra ;

Schneeberger, Achim ;

von Bonin, Arne ;

Mattner, Frank ;

Schmidt, Walter ;

Staffler, Guenther .

PLOS ONE, 2014, 9 (12)

[3] Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial [J].

Giugliano, Robert P. ;

Pedersen, Terje R. ;

Park, Jeong-Gun ;

De Ferrari, Gaetano M. ;

Gaciong, Zbigniew A. ;

Ceska, Richard ;

Toth, Kalman ;

Gouni-Berthold, Ioanna ;

Lopez-Miranda, Jose ;

Schiele, Francois ;

Mach, Francois ;

Ott, Brian R. ;

Kanevsky, Estelle ;

Pineda, Armando Lira ;

Somaratne, Ransi ;

Wasserman, Scott M. ;

Keech, Anthony C. ;

Sever, Peter S. ;

Sabatine, Marc S. .

LANCET, 2017, 390 (10106) :1962-1971

[4] Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease [J].

Bowman L. ;

Hopewell J.C. ;

Chen F. ;

Wallendszus K. ;

Stevens W. ;

Collins R. ;

Wiviott S.D. ;

Cannon C.P. ;

Braunwald E. ;

Sammons E. ;

Landray M.J. ;

Jiang L. ;

Armitage J. ;

Haynes R. ;

Maggioni A.P. ;

Angermann C.E. ;

Ertl G. ;

Wanner C. ;

Pedersen T. ;

Goto S. ;

Teramoto T. ;

Baigent C. ;

Barter P. ;

Chen Y. ;

Chen Z. ;

Gray A. ;

Mihaylova B. ;

Sleight P. ;

Tobert J. ;

Blaustein R. ;

DeLucca P. ;

Mitchel Y. ;

van Leijenhorst G. ;

Sandercock P. ;

DeMets D. ;

Kjekshus J. ;

Neuberger J. ;

Tonkin A. ;

Emberson J. ;

Granger C. ;

Colhoun H. ;

Barton J. ;

Bray C. ;

Dayanandan R. ;

Knott C. ;

Lay M. ;

Murphy K. ;

Wincott E. ;

Achiri P. ;

Barry S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) :1217-1227

[5] The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice [J].

Landlinger, Christine ;

Pouwer, Marianne G. ;

Juno, Claudia ;

van der Hoorn, Jose W. A. ;

Pieterman, Elsbet J. ;

Jukema, J. Wouter ;

Staffler, Guenther ;

Princen, Hans M. G. ;

Galabova, Gergana .

EUROPEAN HEART JOURNAL, 2017, 38 (32) :2499-U143

[6] Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol [J].

Ray, Kausik K. ;

Landmesser, Ulf ;

Leiter, Lawrence A. ;

Kallend, David ;

Dufour, Robert ;

Karakas, Mahir ;

Hall, Tim ;

Troquay, Roland P. T. ;

Turner, Traci ;

Visseren, Frank L. J. ;

Wijngaard, Peter ;

Wright, R. Scott ;

Kastelein, John J. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) :1430-1440

[7]

Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]

[8] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[9] Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up [J].

Vallejo-Vaz, Antonio J. ;

Robertson, Michele ;

Catapano, Alberico L. ;

Watts, Gerald F. ;

Kastelein, John J. ;

Packard, Chris J. ;

Ford, Ian ;

Ray, Kausik K. .

CIRCULATION, 2017, 136 (20) :1878-+

[10] Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis [J].

Wang, Shaohua ;

Cai, Rongrong ;

Yuan, Yang ;

Varghese, Zac ;

Moorhead, John ;

Ruan, Xiong Z. .

SCIENTIFIC REPORTS, 2017, 7

← 1 →